LncRNA EPR regulates intestinal mucus production and protects against inflammation and tumorigenesis.


Journal

Nucleic acids research
ISSN: 1362-4962
Titre abrégé: Nucleic Acids Res
Pays: England
ID NLM: 0411011

Informations de publication

Date de publication:
09 06 2023
Historique:
accepted: 28 03 2023
revised: 14 03 2023
received: 24 01 2023
medline: 12 6 2023
pubmed: 19 4 2023
entrez: 18 4 2023
Statut: ppublish

Résumé

The long non-coding RNA EPR is expressed in epithelial tissues, binds to chromatin and controls distinct biological activities in mouse mammary gland cells. Because of its high expression in the intestine, in this study we have generated a colon-specific conditional targeted deletion (EPR cKO) to evaluate EPR in vivo functions in mice. EPR cKO mice display epithelium hyperproliferation, impaired mucus production and secretion, as well as inflammatory infiltration in the proximal portion of the large intestine. RNA sequencing analysis reveals a rearrangement of the colon crypt transcriptome with strong reduction of goblet cell-specific factors including those involved in the synthesis, assembly, transport and control of mucus proteins. Further, colon mucosa integrity and permeability are impaired in EPR cKO mice, and this results in higher susceptibility to dextran sodium sulfate (DSS)-induced colitis and tumor formation. Human EPR is down-regulated in human cancer cell lines as well as in human cancers, and overexpression of EPR in a colon cancer cell line results in enhanced expression of pro-apoptotic genes. Mechanistically, we show that EPR directly interacts with select genes involved in mucus metabolism whose expression is reduced in EPR cKO mice and that EPR deletion causes tridimensional chromatin organization changes.

Identifiants

pubmed: 37070602
pii: 7127543
doi: 10.1093/nar/gkad257
pmc: PMC10250242
doi:

Substances chimiques

RNA, Long Noncoding 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5193-5209

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Nucleic Acids Research.

Références

Am J Physiol Cell Physiol. 2019 Jul 1;317(1):C93-C100
pubmed: 31042423
Dev Dyn. 1995 Apr;202(4):325-32
pubmed: 7626790
Neoplasia. 2017 Aug;19(8):649-658
pubmed: 28732212
Gastroenterology. 2006 Jul;131(1):117-29
pubmed: 16831596
Mucosal Immunol. 2017 Jan;10(1):91-103
pubmed: 27143302
Traffic. 2006 Jan;7(1):85-96
pubmed: 16445689
Nucleic Acids Res. 2022 Jul 22;50(13):7608-7622
pubmed: 35748870
RNA Biol. 2020 Nov;17(11):1628-1635
pubmed: 31847691
Cancer Res. 2007 Oct 15;67(20):9721-30
pubmed: 17942902
Adv Drug Deliv Rev. 2018 Jan 15;124:3-15
pubmed: 28970050
Nat Rev Mol Cell Biol. 2023 Jun;24(6):430-447
pubmed: 36596869
Science. 1996 Oct 11;274(5285):262-5
pubmed: 8824194
Curr Treat Options Gastroenterol. 2006 Jun;9(3):211-20
pubmed: 16901385
Curr Protoc Immunol. 2014 Feb 04;104:15.25.1-15.25.14
pubmed: 24510619
Science. 2015 Nov 13;350(6262):830-4
pubmed: 26564856
Sci Rep. 2019 Jan 29;9(1):888
pubmed: 30696875
Trends Cancer. 2022 Nov;8(11):901-914
pubmed: 35907753
Genome Biol. 2016 Jun 15;17(1):127
pubmed: 27306882
Front Immunol. 2020 Sep 04;11:2054
pubmed: 33013869
Gastroenterology. 2021 Dec;161(6):1924-1939
pubmed: 34478742
Histochem Cell Biol. 2020 Jun;153(6):413-429
pubmed: 32162136
Nat Protoc. 2021 Jan;16(1):61-85
pubmed: 33318692
J Exp Med. 2007 Jun 11;204(6):1417-29
pubmed: 17517967
Nat Protoc. 2014 Sep;9(9):2045-60
pubmed: 25079428
Annu Rev Cell Dev Biol. 2017 Oct 6;33:265-289
pubmed: 28783961
FASEB J. 1998 Feb;12(2):249-52
pubmed: 9472990
Methods Mol Biol. 2015;1270:321-46
pubmed: 25702127
Gastroenterology. 2022 Mar;162(3):715-730.e3
pubmed: 34757143
Biomed Res Int. 2020 Nov 22;2020:1216325
pubmed: 33299853
J Cell Physiol. 2021 Nov;236(11):7801-7813
pubmed: 33899236
Trends Genet. 2017 Jul;33(7):464-478
pubmed: 28535931
Nature. 2019 Mar;567(7746):49-55
pubmed: 30814735
Nature. 2021 Sep;597(7875):250-255
pubmed: 34497389
Curr Protoc Mouse Biol. 2013 Dec 19;3(4):217-40
pubmed: 25105065
Nucleic Acids Res. 2020 Sep 18;48(16):9053-9066
pubmed: 32756918
Cell. 2019 Nov 14;179(5):1033-1055
pubmed: 31730848
Gut. 2019 Dec;68(12):2142-2151
pubmed: 30914450
Trends Mol Med. 2018 Mar;24(3):257-277
pubmed: 29449148
J Cell Biol. 2019 Jan 7;218(1):27-38
pubmed: 30181316
Oncotarget. 2017 Mar 7;8(10):16811-16828
pubmed: 28187432
Nature. 2018 Oct;562(7727):367-372
pubmed: 30283141
Nat Rev Gastroenterol Hepatol. 2022 Dec;19(12):785-803
pubmed: 36097076
F1000Res. 2015 Nov 20;4:1310
pubmed: 26835000
Nat Rev Mol Cell Biol. 2018 Mar;19(3):143-157
pubmed: 29138516
Nat Commun. 2019 Apr 29;10(1):1969
pubmed: 31036808
Nat Protoc. 2007;2(7):1722-33
pubmed: 17641637
Nat Cell Biol. 2019 May;21(5):542-551
pubmed: 31048766
Nat Rev Genet. 2019 Aug;20(8):437-455
pubmed: 31086298

Auteurs

Paola Briata (P)

Gene Expression Regulation Laboratory, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Luca Mastracci (L)

Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Pathology Unit, Department of Surgical and Diagnostic Sciences (DISC), University of Genoa, Genova, Italy.

Ettore Zapparoli (E)

Center for Omics Sciences, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.

Luca Caputo (L)

Development, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

Elisa Ferracci (E)

Laboratory of Stem Cells and Cancer Genomics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.

Alessandra Silvestri (A)

IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milano, Italy.

Anna Garuti (A)

Translational Genomics, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Meriem Hadjer Hamadou (MH)

Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.

Alberto Inga (A)

Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.

Elisa Marcaccini (E)

Gene Expression Regulation Laboratory, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Federica Grillo (F)

Pathology Unit, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.
Pathology Unit, Department of Surgical and Diagnostic Sciences (DISC), University of Genoa, Genova, Italy.

Gabriele Bucci (G)

Center for Omics Sciences, IRCCS Ospedale San Raffaele, 20132 Milano, Italy.

Pier Lorenzo Puri (PL)

Development, Aging and Regeneration Program, Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA.

Galina Beznoussenko (G)

The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy.

Alexander Mironov (A)

The AIRC Institute of Molecular Oncology, Via Adamello 16, 20139 Milano, Italy.

Fulvio Chiacchiera (F)

Laboratory of Stem Cells and Cancer Genomics, Department of Cellular, Computational and Integrative Biology (CIBIO), University of Trento, Trento, Italy.

Roberto Gherzi (R)

Gene Expression Regulation Laboratory, IRCCS Ospedale Policlinico San Martino, 16132 Genova, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH